In this webinar with Beverley Sarstedt you will take away:
-Getting the basics right: exploring genetic risk factors and key interventions
-The relevance of biofilms and implications for testing.
-Understanding different types of biofilm disruptors and when to use.
-Understanding the difference between PCR and NGS testing and implications for clinical decision-making.
-Explore two detailed case histories using the Microgen WomenKey with urine and vaginal testing and Microgen MensKey with urine and semen testing.
Download the slides here.
Watch the recording below: